Pipmed Medical
Indocyanine green (lCG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm and emits near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, enters the intestine through the biliary tract, and is finally excreted with feces.
Our ICG is a high-purity injection that has passed rigorous consistency evaluations. With its low impurity content and optimized storage conditions, it provides stable and reliable diagnosis and treatment options to the medical community.



Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, it helps identify the capsule and internal limiting membrane to reduce complications.
Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, and biliary tract development.
Advantages: Rapidity, accuracy, and safety make it the optimal method to evaluate liver function, supporting surgical decisions and improving safety.
Indications: Tumor localization, lymphatic system imaging, and blood supply assessment.
Advantages: Enhances target visibility during operations through intuitive fluorescence signals.



Our product range includes high-end medical devices (fluorescence imaging series), fluorescence contrast agents (ICG, targeted agents), and core components (CMOS camera modules, endoscopes). These solutions have been implemented in more than 500 large hospitals.
Founded in 2011, we focus on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD). Our mission is to become a global leader in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
As a specialized enterprise, we have undertaken numerous national and provincial key research projects. We hold over 130 core invention patents globally. We have established strategic partnerships with international leaders and serve customers in more than 10 overseas countries.